Antisense oligonucleotides in neuroendocrinology: Enthusiasm and frustration

Neurochemistry International

Volumn 31, Issue 3, 1997, Pages 363-378

  Neumann, Inga ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; MESSENGER RNA; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; OXYTOCIN; PROTEIN C FOS; VASOPRESSIN; VASOPRESSIN RECEPTOR;

CORTICOTROPIN RELEASE; DRINKING BEHAVIOR; ELECTROPHYSIOLOGY; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MEDIAN EMINENCE; NERVE STIMULATION; NEUROENDOCRINOLOGY; NONHUMAN; OXYTOCIN RELEASE; PRIORITY JOURNAL; REVIEW; SENSORY NERVE; SUCKLING; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; VASOPRESSIN RELEASE;

EID: 0030756828     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00107-6     Document Type: Article

References (80)

1. Akabayashi, A., Wahlestedt, C., Alexander, J. T. and Leibowitz, S. F. (1994) Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. Mol. Brain Res. 21, 55-61.
2. 1 receptor. Regul. Pept. 59, 171-182.
3. Baertschi, A. F. (1994) Antisense oligonucleotide strategies in physiology. Mol. Cell. Endocrinol. 101, R15-R24.
4. Bourque, C. W. and Renaud, L. P. (1990) Electrophysiology of mammalian magnocellular vasopressin and oxytocin neurosecretory neurons. Front. Neuroendocrinol. 11, 183-212.
5. Burford, G. D., Clifford, P., Jones, C. W. and Pickering, B. T. (1973) A model for the passage of the neurohypophysial hormones and their related proteins through the rat neurohypophysis. Biochem. J. 136, 1053-1058.
6. 1 receptor mRNA expression. J. Neurosci. 15, 6340-6350.
7. Chiasson, B. J., Armstrong, J. N., Hooper, M. L., Murphy, P. R. and Robertson, H. A. (1994) The application of antisense oligonucleotide technology to the brain: some pitfalls. Cell. Mol. Neurobiol. 14, 507-521.
8. DeGoeji, D. C. E., Kvetnansky, R., Whitnall, M. H., Jezova, D., Berkenbosch, F. and Tilders, F. J. H. (1991) Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. Neuroendocrinology 53, 150-159.
9. De Souza, E. B., Insel, T. R., Perrin, M. H., Rivier, J., Vale, W. and Kuhar, M. J. (1985) Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J. Neurosci. 5, 3189-3203.
10. De Souza, E. B. (1987) Corticotropin-releasing factor receptors in the rat central nervous system, characterization and regional distribution. J. Neurosci. 7, 88-100.
11. Fenelon, V. S., Poulain, D. A. and Theodosis, D. T. (1993) Oxytocin neuron activation and Fos expression: a quantitative immunocytochemical analysis of the effect of lactation, parturition, osmotic and cardiovascular stimulation. Neuroscience 53, 77-89.
12. Gainer, H., Sarne, Y. and Brownstein, M. J. (1977) Biosynthesis and axonal transport of rat neurohypophysial proteins and peptides. J. Cell. Biol. 73, 366-381.
13. Gillies, G. E., Linton, E. A. and Lowry, P. J. (1982) Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299, 355-357.
14. Gyurko, R., Wielbo, D. and Phillips, M. I. (1993) Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul. Pept. 49, 167-174.
15. Hatzinger, M., Reul, J. M. H. M., Landgraf, R., Holsboer, F. and Neumann, J. (1996) Combined Dexamethasone/CRH test in rats: HPA system alterations in aging. Neuroendocrinology 64, 349-356.
16. Hamamura, M., Leng, G., Emson, P. C. and Kiyama, H. (1991) Electrical activation and c-fos mRNA expression in rat neurosecretory neurones after systemic administration of cholecystokinin. J. Physiol. 444, 51-63.
17. Hanahan, D. (1989) Transgenic mice as probes into complex systems. Science 246, 1265-1275.
18. Heuser, I., Yassouridis, A. and Holsboer, F. (1994) The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 28, 341-356.
19. Heuser, I. J., Gotthardt, U., Schweiger, U., Schmider, J., Lammers, C. H., Dettling, M. and Holsboer, F. (1994) Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender. Neurobiol. Aging 15, 227-231.
20. Higuchi, T., Tadekoro, Y., Honda, K. and Negoro, H. (1986) Detailed analysis of blood oxytocin levels during suckling and parturition in the rat. J. Endocrinol. 110, 251-256.
21. Hoffman, G. E., Smith, M. S. and Verbalis, J. G. (1983) C-fos and related immmediate early gene products as markers of activity in neuroendocrine systems. Front. Neuroendocrinol. 3, 173-213.
22. Holsboer, F. (1989) Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity. Eur. Arch. Psych. Neurol. Sci. 238, 302-322.
23. Imaki, T., Shibasaki, T., Wang, X. and Demura, H. (1995) Intracerebroventricular administration of corticotropin-releasing factor antagonist attenuates c-fos mRNA expression in the paraventricular nucleus after stress. Neuroendocrinology 61, 445-452.
24. Jaenisch, R. (1988) Transgenic animals. Science 240, 1468-1473.
25. Kalra, P. S., Bonavera, J. J. and Kalra, S. P. (1995) Central administration of antisense oligodeoxynucleotides to neuropeptide Y (NPY) mRNA reveals the critical role of newly synthesized NPY in regulation of LHRH release. Regul. Pept. 59, 215-220.
26. Kiss, J. Z., Mezey, E. and Skirboll, L. (1984) Corticotropin-releasing factor immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy. Proc. Natl. Acad. Sci. U.S.A. 84, 1854-1858.
27. Lambert, R. C., Moos, F. C. and Richard, P. H. (1993) Action of endogenous oxytocin within the paraventricular or supraoptic nuclei: a powerful link in the regulation of the bursting pattern of oxytocin neurons during the milk-ejection reflex in rats. Neuroscience 57, 1027-1038.
28. Landgraf, R., Gerstberger, R., Montkowski, A., Probst, J. C., Wotjak, C. T., Holsboer, F. and Engelmann, M. (1995) V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities and anxiety-related behavior in rats. J. Neurosci. 15, 4250-4258.
29. Landgraf, R. (1995) Intracerebrally released vasopressin and oxytocin: measurement, mechanisms and behavioural consequences. J. Neuroendocrinol. 7, 243-253.
30. Legendre, P. and Poulain, D. A. (1992) Intrinsic mechanisms involved in the electrophysiological properties of the vasopressin-releasing neurons of the hypothalamus. Prog. Neurobiol. 38, 1-17.
31. Leng, G., Way, S. and Dyball, R. E. J. (1991) Identification of oxytocin cell in the rat supraoptic nucleus by their response to cholecystokinin injection. Neurosci. Lett. 122, 159-162.
32. Liebsch, G., Landgraf, R., Gerstberger, R., Probst, J. C., Wotjak, C. T., Engelmann, M., Holsboer, F. and Montkowski, A. (1995) Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul. Pept. 59, 229-240.
33. Lightman, S. L. and Young, W. S. III (1987) Vasopressin, oxytocin, dynorphin, enkephalin, and corticotrophin releasing factor mRNA stimulation in the rat. J. Physiol. 394, 23-39.
34. Lledo, P. M., Mason, W. T. and Zorec, R. (1994) Study of stimulus-secretion coupling in single cells using antisense oligodeoxynucleotides and patch clamp technique to inhibit specific protein expression. Cell. Mol. Neurobiol. 14, 539-556.
35. Loke, S. L., Stein, C. A., Zhang, X. H., Mori, K., Nakanishi, M., Subasinghe, C., Cohen, J. S. and Neckers, L. M. (1989) Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. U.S.A. 86, 3474-3478.
36. Luckman, S. M., Dyball, R. E. J. and Leng, G. (1994) Induction of c-fos expression in hypothalamic magnocellular neurons requires synaptic activation and not simply increased spike activity. J. Neurosci. 14, 4825-4830.
37. Ludwig, M., Callahan, M. F., Neumann, I., Landgraf, R. and Morris, M. (1994) Systemic osmotic stimulation increases vasopressin and oxytocin release within the supraoptic nucleus. J. Neuroendocrinol. 6, 369-373.
38. McCarthy, M. M., Kleopoulos, S. P., Mobbs, C. V. and Pfaff, D. W. (1994) Infusion of antisense oligodeoxynucleotides to the oxytocin receptor in the ventro-medial hypothalamus reduces estrogen-induced sexual receptivity and oxytocin receptor binding in the female rat. Neuroendocrinology 59, 432-440.
39. McCarthy, M. M. (1994) Use of antisense oligodeoxynucleotides to block gene expression in central nervous system. Methods Neurosci. 22, 342-356.
40. Meeker, R., LeGrand, G., Ramirez, J., Smith, T. and Shih, Y.-H. (1995) Antisense vasopressin oligonucleotides: uptake, turnover, distribution, toxicity and behavioral effects. J. Neuroendocrinol. 7, 419-428.
41. Moos, F. C., Freund-Mercier, M. J., Guerne, Y., Guerne, J. M., Stoeckel, M. E. and Richard, P. H. (1984) Release of oxytocin and vasopressin by magnocellular nuclei in vitro: specific facilitatory effect of oxytocin on its own release. J. Endocrinol. 268, E537-E545.
42. Morgan, J. I. and Curran, T. (1991) Stimulus-transcription coupling in the nervous system: involvement of inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14, 421-451.
43. Morris, J. F., Pow, D. V., Sokol, H. A. and Ward, A. (1993) Dendritic release of peptides from magnocellular neurons in normal rats, Brattleboro rats and mice with hereditary nephrogenic diabetes insipidus. In Vasopressin (Gross P., Richter D., Robertson G.L. Eds.), pp. 171-182. John Libbey, London.
44. Morris, M., Callahan, M. F., Li, P. and Lucion, A. B. (1995) Central oxytocin mediates stress-induced tachycardia. J. Neuroendocrinol. 7, 455-459.
45. Neumann, I., Russell, J. A. and Landgraf, R. (1993a) Oxytocin and vasopressin release within the supraoptic and paraventricular nuclei of pregnant, parturient and lactating rats: a microdialysis study. Neuroscience 53, 65-75.
46. Neumann, I., Ludwig, M., Pittman, Q. J. and Landgraf, R. (1993b) Simultaneous microdialysis in blood and brain: oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat. Neuroendocrinology 58, 637-645.
47. Neumann, I., Koehler, E., Landgraf, R. and Summy-Long, J. (1994a) Administration of an oxytocin antagonist into the rat supraoptic nucleus attenuates intranuclear and peripheral oxytocin release in conscious lactating rats during suckling. Endocrinology 134, 141-148.
48. Neumann, I., Landgraf, R., Takahashi, Y., Pittman, Q. J. and Russell, J. A. (1994b) Stimulation of oxytocin release within the supraoptic nucleus and into blood by CCK-8. Am. J. Physiol. 267, R1626-R1631.
49. Neumann, I., Porter, D. W. F., Landgraf, R. and Pittman, Q. J. (1994c) Rapid effect on suckling of an oxytocin antisense oligonucleotide administered into rat supraoptic nucleus. Am. J. Physiol. 267, R852-R858.
50. Neumann, I., Kremarik, P. and Pittman, Q. J. (1995a) Acute sequence-specific effects of oxytocin and vasopressin antisense oligonucleotides on neuronal responses. Neuroscience 69, 997-1004.
51. Neumann, I., Landgraf, R., Bauce, L. and Pittman, Q. J. (1995b) Osmotic responsiveness and crosstalk involving oxytocin, but not vasopressin or amino acids between the supraoptic nuclei in virgin and lactating rats. J. Neurosci. 15, 3408-3417.
52. Neumann, I., Douglas, A. J., Pittman, Q. J., Russell, J. A. and Landgraf, R. (1996) Oxytocin released within the supraoptic nucleus of the rat brain by positive feedback action is involved in parturition-related events. J. Neuroendocrinol. 8, 227-233.
53. Nordmann, J. J. (1982) Evidence for an aging process within neurosecretory granules. In Neuroendocrinology of Vasopressin, Corticoliberin and Opiome lanocort ins (Baertschi A. J., Dreifuss J. J. Eds.), pp. 11-20. Academic, London.
54. Ogawa, S., Olazabal, U. E., Parhar, I. S. and Pfaff, D. W. (1994) Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproductive behavior and progesterone receptor immunoreactivity in female rat. J. Neurosci. 14, 1766-1774.
55. Ortigao, J. F. R., Rosch, H., Selter, H., Frohlich, A., Lorenz, A., Montenarh, M. and Seliger, H. (1992) Antisense effect of oligodeoxynucleotides with inverted terminal internucleotide linkages: a minimal modification protecting against nucleolytic degradation. Antisense Res. Devl. 2, 129-146.
56. Ono, N., Samson, W. K., McDonald, J. K., Lumpkin, M. D., DeCastro, J. C. B. and McCann, S. M. (1985) Effects of intravenous and intraventricular injection of antisera directed against corticotropin-releasing factor on the secretion of anterior pituitary hormones. Proc. Natl. Acad. Sci. U.S.A. 82, 7787-7790.
57. Pich, E. M., Koob, G. F., Heilig, M., Menzaghi, F., Vale, W. and Weiss, F. (1993) Corticotropin-releasing factor release from the mediobasal hypothalamus of the rat as measured by microdialysis. Neuroscience 55, 695-707.
58. Pow, D. V. and Morris, J. F. (1989) Dendrites of hypothalamic magnocellular neurons release neurohypophysial peptides by exocytosis. Neuroscience 32, 435-439.
59. Rivier, C. and Vale, W. (1983) Interaction of corticotropin-releasing factor and arginine-vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113, 939-942.
60. 1) receptor antisense oligonucleotides attenuate thirst in the rat. Regul. Pept. 59, 183-192.
61. Sawchenko, P. E., Swanson, L. W. and Vale, W. (1984) Coexpression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc. Natl. Acad. Sci. U.S.A. 81, 1883-1887.
62. Sherman, T. G., Civelli, O., Douglass, J., Herbert, E. and Watson, S. J. (1986) Coordinate expression of hypothalamic pro-dynorphin and pro-vasopressin mRNAs with osmotic stimulation. Neuroendocrinology 44, 222-228.
63. Silverman, A. J., Hou-Yu, A. and Chen, W. P. (1989) Corticotropin-releasing factor synapses within the paraventricular nucleus of the hypothalamus. Neuroendocrinology 49, 291-299.
64. Skutella, T., Probst, J. C., Engelmann, M., Wotjak, C. T., Landgraf, R. and Jirikowski, G. F. (1994) Vasopressin antisense oligonucleotide induces temporary diabetes insipidus in rats. J. Neuroendocrinol. 6, 121-125.
65. Sladek, C. D., Mathiasen, J. R., Ludwig, M., Morris, M., Maciejewski-Lenoir, D. and Bloom, F. E. (1995) Effects of exogenous vasopressin mRNA and antisense oligodeoxynucleotides on vasopressin and oxytocin release in vitro. 1st Joint World Congress of Neurohypophysis and Vasopressin, Nasu, Japan p. 24, 106 (abstract).
66. Standifer, K. M., Chien, C. C., Wahlestedt, C., Brown, G. P. and Pasternak, G. W. (1994) Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron 12, 805-810.
67. Stein, C. A. (1995) Does antisense exist? Nature Med. 1, 1119-1121.
68. Stein, C. A. and Krieg, A. (1994) Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res. Devl. 4, 67-69.
69. Suzuki, S., Pilowsky, P., Minson, J., Arnolda, L., Llewellyn-Smith, I. J. and Chalmers, J. (1994) c-fos antisense in rostral ventral medulla reduces arterial blood presure. Am. J. Physiol. 266, R1418-R1422.
70. Theodosis, D. T. (1985) Oxytocin-immunoreactive terminals synapse on oxytocin neurones in the supraoptic nucleus. Nature 313, 682-684.
71. Van Tol, H. H. M., Voorhuis, T. A. M. and Burbach, J. P. H. (1987) Oxytocin gene expression in discrete hypothalamic magnocellular cell groups is stimulated by prolonged salt loading. Endocrinology 120, 71-76.
72. Verbalis, J. G., McCann, M. J., McHale, C. and Stricker, E. M. (1986) Oxytocin secretion in response to cholecystokinin and food intake: differentiation of nausea from satiety. Science 232, 1417-1419.
73. Verbalis, J. G., Stricker, E. M., Robinson, A. G. and Hoffman, G. E. (1991) Cholecystokinin activates c-fos expression in hypothalamic oxytocin and corticotropin-releasing hormone neurons. J. Neuroendocrinol. 3, 205-213.
74. Vlassov, V. V., Balakireva, L. A. and Yakubov, L. A. (1994) Transport of oligonucleotides across natural and model membranes. Biochem. Biophys. Acta 1197, 95-108.
75. Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F. and Heilig, M. (1993) Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259, 528-534.
76. Whitnal, M. H., Smyth, D. and Gainer, H. (1987) Vasopressin coexists in half of the corticotropin-releasing factor axons present in the external zone of the median eminence in normal rats. Neuroendocrinology 45, 420-424.
77. Wotjak, C. T., Ludwig, M. and Landgraf, R. (1994) Vasopressin facilitates its own release within the rat supraoptic nucleus in vivo. NeuroRep. 5, 1181-1184.
78. Wotjak, C. T., Kubota, M., Ganster, J., Liebsch, G., Holsboer, F., Neumann, J. and Landgraf, R. (1996) Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: A novel mechanism of regulating ACTH secretion? J. Neurosci. 16, 7725-7732.
79. Yakubov, L. A., Deeva, E. A., Zarytova, V. F., Ivanova, E. M., Ryte, A. S., Yurchenko, L. V. and Vlassow, V. V. (1989) Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc. Natl. Acad. Sci. U.S.A. 86, 6454-6458.
80. Zingg, H.H. and Lefebvre, D. L. (1992) Oxytocin and vasopressin gene expression during gestation and lactation. Mol. Brain Res. 4, 1-6.